Stock BNR BURNING ROCK BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Burning Rock Biotech Limited

Equities

BNR

US12233L1070

Delayed Nasdaq
Other stock markets
 03:50:01 2024-04-19 pm EDT 		5-day change 1st Jan Change
0.761 USD -4.88% Intraday chart for Burning Rock Biotech Limited +0.13% -18.17%
Apr. 02 Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M MT
Apr. 02 Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90 MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Revenue $75.7M
MT
Earnings Flash (BNR.L) BURNING ROCK BIOTECH Posts FY23 Loss $-0.90
MT
Transcript : Burning Rock Biotech Limited, Q4 2023 Earnings Call, Mar 29, 2024
Burning Rock Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Earnings Flash (BNR) BURNING ROCK BIOTECH LIMITED Posts Q4 Revenue RMB121.1M
MT
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Burning Rock Announces Receipt of Notification from NASDAQ
GL
Burning Rock Biotech Receives Nasdaq Listing Requirement Notice
MT
Burning Rock Biotech Gets Non-Compliance Notice From Nasdaq
MT
Burning Rock Announces Results of 2023 Annual General Meeting
GL
Transcript : Burning Rock Biotech Limited, Q3 2023 Earnings Call, Nov 30, 2023
MORNING BID AMERICAS-November bids adieu with inflation data, OPEC
RE
Burning Rock Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Burning Rock Reports Third Quarter 2023 Financial Results
GL
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
GL
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
GL
Burning Rock, Boehringer Ingelheim Unveil Agreement Targeting Oncology Companion Diagnostics
MT
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
GL
Burning Rock and Boehringer Ingelheim Achieves Master Service Agreement in Oncology Companion Diagnostics
CI
Burning Rock Biotech Receives Breakthrough Device Designation in China for Multi-cancer Test
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BNR Stock
  4. News Burning Rock Biotech Limited